Virtual Reality in Motor Performance and Quality of Life in Patients With Parkinson's Disease

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Ailton de Souza Melo, Federal University of Bahia
ClinicalTrials.gov Identifier:
NCT01120392
First received: May 10, 2010
Last updated: December 6, 2011
Last verified: December 2011
  Purpose

Treatment with Nintendo wii is higher to physical therapy conventional in the quality of life and motor performance in patients with Parkinson's disease.


Condition Intervention Phase
Parkinson Disease
Other: treatment with Nintendo wii.
Other: Physical therapy conventional.
Phase 2
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Virtual Reality in Motor Performance and Quality of Life in Patients With Parkinson's Disease

Resource links provided by NLM:


Further study details as provided by Federal University of Bahia:

Primary Outcome Measures:
  • Quality of life [ Time Frame: 4 weeks (Baseline and after four weeks) ] [ Designated as safety issue: No ]
    Parkinson's disease questionnaire (PDQ-39)

  • Motor performance [ Time Frame: 4 weeks (Baseline and after four weeks) ] [ Designated as safety issue: No ]
    the Unified Parkinson's Disease Rating Scale (UPDRS.)


Enrollment: 40
Study Start Date: May 2011
Study Completion Date: October 2011
Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Treatment group - Nintendo wii. Other: treatment with Nintendo wii.
Participants Will receive treatment with Nintendo Wii over one months. These Patients Will Be subjected to mobilization of stem and stretching. Then Will Be Submitted to Nintendo wii games. Will Be Submitted This group three times a week to a treatment protocol with boxing exercises with wii sports and wii fit
Active Comparator: conventional - Physical Therapy Other: Physical therapy conventional.
Conventional exercises used with the same goals for the group with wii

Detailed Description:

The aim of this study is to assess if the treatment of rehabilitation with Nintendo wii is higher to the conventional in the quality of life and motor performance in patients with Parkinson's disease.

  Eligibility

Ages Eligible for Study:   50 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Clinical diagnosis of Parkinson's disease
  • Both the sex with age between 50 and 80 years
  • To be in it I serve as apprentice of 1 the 3,0 in the scale of Hoehn Yahr

Exclusion Criteria:

  • Cognitive impairment
  • Poorly controlled arterial hypertension
  • Poorly controlled Cardiopathy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01120392

Locations
Brazil
Ambulatorio Magalhães Neto
Salvador, Bahia, Brazil
Sponsors and Collaborators
Federal University of Bahia
Investigators
Principal Investigator: Ailton Melo, PhD UFBA- DINEP
  More Information

No publications provided

Responsible Party: Ailton de Souza Melo, PhD, Federal University of Bahia
ClinicalTrials.gov Identifier: NCT01120392     History of Changes
Other Study ID Numbers: DNEP
Study First Received: May 10, 2010
Last Updated: December 6, 2011
Health Authority: Brazil: National Committee of Ethics in Research

Keywords provided by Federal University of Bahia:
Parkinson's disease
Physical therapy
Virtual Reality
Quality of life
Motor performance

Additional relevant MeSH terms:
Parkinson Disease
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases

ClinicalTrials.gov processed this record on September 29, 2014